gene-therapy

Geron Corp. (GERN)

ArctosFXAdmin / March 27, 2026

Geron Corp. (NASDAQ: GERN) is a commercial-stage biopharmaceutical company dedicated to changing the lives of patients by changing the course of […]

Earnings, Stocks

PGEN Earnings – Q4 2025

ArctosFXAdmin / March 26, 2026

Precigen, Inc. (NASDAQ: PGEN) released its Q4 and full-year 2025 results on March 25, 2026. The narrative is shifting from

Analysis, Stocks

Precigen Inc. (PGEN)

ArctosFXAdmin / March 26, 2026

Precigen Inc. (NASDAQ: PGEN) is a biopharmaceutical company that focuses on advancing the next generation of gene and cell therapies

ARCTOS FX LLC is registered as a Commodity Trading Advisor (CTA) with the National Futures Association. Trading foreign exchange on margin carries a high level of risk and may not be suitable for all investors. Past performance is not indicative of future results.

gene-therapy

Geron Corp. (GERN)

PGEN Earnings – Q4 2025

Precigen Inc. (PGEN)

© 2026 Arctos FX